$13.850
+0.906 (+6.54%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de SNSE por análisis de gráficos similares
Alphio's SNSE stock price prediction model matches the current Faeth Therapeutics, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.99 (+1.01%). The 1-week path is $13.73 (-0.87%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Faeth Therapeutics, Inc?
SNSE is not a good buy right now for a Beginner investor focused on long-term holding. The stock is showing short-term oversold conditions and there is fresh bullish analyst coverage, but there is no proprietary buy signal, no supportive financial snapshot, and insider selling is rising sharply. Given the clinical-stage biotech profile and the lack of confirmed momentum or fundamentals in the provided data, the better call is to wait rather than buy aggressively today.
SNSE cerró en $13.85 el Monday, tras subir +6.54%
Faeth Therapeutics, Inc (SNSE) last closed at $13.85, gaining +6.54%. These facts feed the 1-day and 1-week SNSE price prediction above.
Factores de la previsión
Los factores de la previsión de Faeth Therapeutics, Inc (SNSE) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de SNSE, ordenadas por similitud.
Análisis de estacionalidad de SNSE
Historically the probability of a positive September return for SNSE is 0.00%. April offers the highest probability of a positive month at 67.19%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de SNSE
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $7.54 | $9.47 | $10.08 | -31.65% |
| Oct 2026 | $6.03 | $7.00 | $8.81 | -49.48% |
| Nov 2026 | $7.71 | $8.96 | $10.60 | -35.30% |
| Dec 2026 | $7.45 | $7.80 | $8.50 | -43.66% |
En 2026, se proyecta que Faeth Therapeutics, Inc (SNSE) oscile entre $6.03 y $10.60.
Previsión mensual de Faeth Therapeutics, Inc para 2026
En Sep de 2026, se proyecta que Faeth Therapeutics, Inc promedie $9.47, con un mínimo de $7.54 y un máximo de $10.08.
En Oct de 2026, se proyecta que Faeth Therapeutics, Inc promedie $7.00, con un mínimo de $6.03 y un máximo de $8.81.
En Nov de 2026, se proyecta que Faeth Therapeutics, Inc promedie $8.96, con un mínimo de $7.71 y un máximo de $10.60.
En Dec de 2026, se proyecta que Faeth Therapeutics, Inc promedie $7.80, con un mínimo de $7.45 y un máximo de $8.50.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.